# A Safety and Efficacy Study of SABER®-Bupivacaine for Pain Following Hernia Repair

> **NCT00974350** · PHASE2 · COMPLETED · sponsor: **Durect** · enrollment: 124 (actual)

## Conditions studied

- Postoperative Pain
- Hernia
- Surgery

## Interventions

- **DRUG:** SABER-Bupivacaine
- **DRUG:** SABER-Bupivacaine
- **DRUG:** SABER-Placebo

## Key facts

- **NCT ID:** NCT00974350
- **Lead sponsor:** Durect
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-01
- **Primary completion:** 2007-10
- **Final completion:** 2007-10
- **Target enrollment:** 124 (ACTUAL)
- **Last updated:** 2021-05-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00974350

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00974350, "A Safety and Efficacy Study of SABER®-Bupivacaine for Pain Following Hernia Repair". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00974350. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*